NEUROPEPTIDE REGULATION OF IMMUNITY

In this review, modern ideas about the neuropeptide regulation of the functions of the immune system in maintaining dynamic homeostasis are argued. Discovered on immunocompetent cells receptors to many known neuropeptides prove their participation in the realization of the efferent link of the neuroimmune interaction. Along with the considerable volume presented in this review of research works on this topic, the question of the specific effect of individual groups of neuropeptides on the immune system remains insufficiently studied; thereby making further research in this direction is actual and significant.

Sudakov K.V. Functional systems. [Funktsional’nye sistemy]. Moscow: Izdatel’stvo RAMN; 2011. (in Russian)

Samotrueva M.A., Yasenyavskaya A.L., Tsibizova A.A., Bashkina O.A., Galimzyanov Kh.M., Tyurenkov I.N. Neuroimmunoendocrinology: modern ideas about molecular mechanisms. Immunologiya. 2017; 38(1): 49-59. (in Russian)

Ashmarin I.P. Hypothesis about the existence of a new higher category in the hierarchy of regulatory peptides. Neyrokhimiya. 1987; 6(1): 23-7. (in Russian)

Ashmarin I.P., Koroleva S.V., Myasoedov N.F. Synactons are functionally related complexes of endogenous regulators. One way to create new drugs (conceptual review). Eksperimental’naya i klinicheskaya farmakologiya. 2006; 69(5): 3-6. (in Russian)

Koroleva S.V., Myasoedov N.F. Dynamic hierarchy of regulatory peptides. Structure of induction couplings of regulators as a target for therapeutic effects. Uspekhi fiziologicheskikh nauk. 2012; 43(3): 38-47. (in Russian)

Ashmarin I.P., Kamenskiy A.A., Lyapina L.A., Myasoedov N.F., Samonina G.E., Levitskaya N.G. et al. Highly stable regulatory oligopeptides: experience and prospects of use. Patologicheskaya fiziologiya i eksperimental’naya terapiya. 2003; 4: 2-5. (in Russian)

de Wied D. The neuropeptide concept. Prog Brain Res. 1987; 72: 93-108.

Ashmarin I.P., Stukalov P.V. Neurochemistry. [Neyrokhimiya]. Moscow: Izd. Instituta biomeditsinskoy khimii RAMN; 1996. (in Russian)

Gabbyasova Yu.R., Tret’yakov D.A., Pleten’ A.P. Peptides of the brain (review). Novaya nauka: sovremennoe sostoyanie i puti razvitiya. 2017; 3(3): 36-41. (in Russian)

Ashmarin I.P., Obukhova M.F. The current state of the hypothesis of a functional continuum of regulatory peptides. Vestnik RAMN. 1994; 10: 28-34. (in Russian)

Gomazkov O.A. Brain and neuropeptides. Reference and information edition. [Mozg i neyropeptidy. Spravochno-informatsionnoe izdanie]. Moscow: Khr. Izd-vo; 1997. (in Russian)

Gomazkov O.A. Neuropeptides are universal regulators. Why? Priroda. 1999; 4: 18-24. (in Russian)

Hershkowitz M., Zwiers H., Gispen W.H. The effect of ACTH on rat brain synaptic plasma membrane lipid fluidity. Biochim Biophys Acta. 1982; 692(3): 495-7.

Sudakov K.V. Immune mechanisms of the systemic activity of the organism: facts and hypotheses. Immunologiya. 2003; 6: 372-81. (in Russian)

Karaulov A.V. Clinical Immunology and Allergology: Textbook. [Klinicheskaya immunologiya i allergologiya : ucheb. posobie]. Moscow: Meditsinskoe informatsionnoe agentstvo; 2002. (in Russian)

Gromov L.A. Neuropeptides. [Neyropeptidy]. Kiev: Zdorov’e; 1992. (in Russian)

Novoselova E.G., Lunin S.M., Khrenov M.O., Novoselova T.V., Fesenko E.E. The involvement of the NF-κB signaling cascade in the realization of the anti-inflammatory activity of thymic peptides. Doklady Akademii nauk. 2009; 428(5): 707-9. (in Russian)

Kuznik B.I., Morozov V.G., Khavinson V.Kh. Cytomedines. 25 years of experience in experimental and clinical research. [Tsitomediny. 25-letniy opyt eksperimental’nykh i klinicheskikh issledovaniy]. St. Petersburg: Nauka; 1998. (in Russian)

Stepanov A.V., Tsepelev V.L., Tsepelev S.L., Ayushiev O.D. Peptide regulators of humoral immunity. [Peptidnye regulyatory gumoral’nogo immunitet]. Chita: Poisk; 2002. (in Russian)

Kustovskaya E.M., Malinin V.V., Gvozdeva O.V. Effect of vilon and epithalon on immunity and hemostasis. Allergologiya i immunologiya. 2007; 8(1): 181. (in Russian)

Rozenberg V.Ya., Korsakov S.V., Kuznik B.I., Kustovskaya E.M. Vilon application in the treatment of oncology in elderly patients with inoperable forms of cancer. Dal’nevostochnyy meditsinskiy zhurnal. 2008; 1: 80-2. (in Russian)

Tsepelev V.L., Tsepelev S.L., Kurupanov S.I. Study of the activity of synthetic bursopeptides in immunodeficiency caused by cyclophosphamide. Byulleten’ Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk. 2003; 23(1): 84-6. (in Russian)

Kholnazarov B.M., Bunyatyan N.D., Shakhmatov A.N., Bobiev G.M. Synthesis of potentially immunoactive lysine-containing peptides. Doklady akademii nauk Respubliki Tadzhikistan. 2013; 56(6): 476-8. (in Russian)

Chereshnev V.A., Geyn C.B. ß-endorphin is an endogenous regulator of immune processes. RFZh im. Sechenova. 2009; 95(12): 1279-90. (in Russian)

Smith E.M. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain, Behavior, and Immunity. 2008; 22(1): 3-14. (in Russian)

Sharp B.M. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav. Immun. 2006; 20: 9-14.

Geyn C.B. Opioidergic regulation of immune reactions. Molekulyarnaya meditsina. 2010; 4: 17-21. (in Russian)

Sein O.B., Besedin M.V., Sein D.O., Vydrin A.M., Naydenkov A.V. Immunotropic effects of opioid peptides. Vestnik Kurskoy gosudarstvennoy sel’skokhozyaystvennoy akademii. 2009; 5: 74-7. (in Russian)

Kamenskiy A.A., Levitskaya N.G. Melanocortin system. Uspekhi fiziologicheskikh nauk. 2009; 1: 44-64. (in Russian)

Lipton J.M., Glyn J.R., Zimmer J.A. ACTH and alpha-melanotropin in central temperature control. Fed Proc. 1981; 40(13): 2760-4.

Chiao H., Foster S., Thomas R., Lipton J., Star R.A. Alfa-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 1996; 97(9): 2038-44.

Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992; 257(5074): 1248-51.

Bhardwaj R., Becher E., Mahnke K., Hartmeyer M., Schwarz T., Scholzen T., Luger Т.А. Evidence for the differential expression of the functional a-melanocyte-stimulating hormon receptor MC-1 on human monocytes. J. Immunol. 1997; 158(7); 3378-84.

Hartmeyer M., Scholzen T., Becher E., Bhardwaj R.S., Schwarz T., Luger T.A. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J. Immunol. 1997; 159(4): 1930-7.

Glazova N.Yu., Sebentsova E.A., Levitskaya N.G., Andreeva L.A., Alfeeva L.Yu., Kamenskiy A.Aet al. Effect of modification of the N-terminal region of the molecule on the expression of nootropic action of Semax analogues. Izvestiya Akademii Nauk, seriya Biologicheskaya. 2005; 4: 460-6. (in Russian)

Levitskaya N.G., Glazova N.Yu., Sebentsova E.A., Manchenko D.M., Vilenskiy D.A., Andreeva L.A. et al. Investigation of the spectrum of physiological activity of analogue ACTG4-10 heptapeptide semax. Neyrokhimiya. 2008; 25(1): 111-8. (in Russian)

Sever’yanova L.A., Bobyntsev I.I., Kryukov A.A. Neuropeptides and active amino acids: effects on various types of pain sensitivity and pain-induced behavior. Patogenez. 2005; 3(1): 23-4. (in Russian)

Zozulya A.A., Kost N.V., Meshavkin V.K., Syunyakov T.S., Teleshova E.V., Andreeva L.A. et al. Peptide pharmacological preparations with psychotropic and neurotropic activity. Psikhiatriya. 2007; 4(28): 55-61. (in Russian)

Najjar V.A., Nishioka K. Tuftsin: a natural phagocytosis stimulating peptide. Nature. 1970; 228: 672-3.

Moghimi S.M., Rajabi-Siahboomi A.R. Recent advances in cellular, subcellular and molecular targeting. Adv. Drug Deliv. Rev. 2000; 41(2): 129-33.

Perel’muter V.M., Odintsov Yu.N., Kliment’eva T.K. Taftsin is a natural immunomodulator. Possible role in tumor progression. Sibirskiy onkologicheskiy zhurnal. 2004; 12(4): С. 57-62. (in Russian)

Babcock G.F., Amoscato A.A., Nishioka K. Effect of tuftsin on the migration, chemotaxis and differentiation of macrophages and granulocytes. Ann. N. Y. Acad. Sci. 1983; 419: 64-74.

Philips J.H., Babcock G.F, Nishioka K. Tuftsin: a natural occurring immunopotentiating factor. In vitro enhancement of murine natural cell-mediated cytotoxity. J. Immunology. 1981; 126(3): 915-21.

Paulesu L., Di Stefano A., Luzzi E., Bocci V., Silvestri S., Nencioni L. Effect of tuftsin and its retro-inverso analogue on the realease of interferon (IFN-y) and tumor necrosis factor (TNF-a) by human leucocytes. Immunol. Lett. 1992; 34(1): 7-11.

Skrebitskiy V.G., Kasyan A.P., Povarov I.S., Kondratenko R.V., Slominskiy P.A. Neuropeptidе Selank: biological activity and fundamental mechanisms of action. Nervnye bolezni. 2016; 4: 52-6. (in Russian)

Kolomin T., Shadrina M., Morozova M., Volkova A., Andreeva L., Slominsky P., et al. The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action. Molecular Immunology. 2014; 58(1): 50-5.

Volkova A., Shadrina M., Kolomin T., Andreeva L., Limborska S., Myasoedov N., Slominsky P. Selank аdministration affects the expression of some genes involved in gabaergic neurotransmission. Frontiers in Pharmacology. 2016; 7: 31.

Vanina V.I., Malkova N.V., Kovalitskaya Yu.A., Kolobov A.A., Kampe-Nemm E.A., Lipkin V.M. et al. The effect of ACTH (11-24) and ACTH-like peptides of immunocortin and leukocorticotropin on the proliferation of rat spleen T and B lymphocytes in vitro. Rossiyskiy immunologicheskiy zhurnal. 2007; 1 (2(10): 139-43. (in Russian)

Abdurasulova I.N., Klimenko V.M., Lyudyno V.I., Langel’ U., Krasnova I.N. Participation of galaninergic brain structures in response to systemic administration of lipopolysaccharide. Byulleten’ eksperimental’noy biologii i meditsiny. 1998; 125(4): 430-2. (in Russian)

Lev N.S. Neuropeptides and other neurohumoral regulators in the pathogenesis of bronchial asthma in children. Rossiyskiy vestnik perinatologii i pediatrii. 2000; 2: 19-23. (in Russian)

Revyakina V.A., Agafonov A.S., Sentsova T.B., Fabrika M.P. The participation of neuropeptides and β-endorphin in the pathogenesis of atopic dermatitis. Evaluation of the efficacy of levocetisine and its effect on the levels of neuropeptides in children with atopic dermatitis. Rossiyskiy allergologicheskiy zhurnal. 2010; 2: 72-8. (in Russian)

Borici-Mazi R., Kouridakis S., Kontou-Fili K. Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: the effect cetirisine and dimethindene. Allergy. 1999; 54(1): 46-56.

Tedeschi A., Lorini M., Asero R. No evidence of increased serum substance P levels in chronic urticaria patients with and without demonstrable circulating vasoactive factors. Clinical Experimental Dermatology. 2005; 30(2): 171-5.

Giler U., Nimayer F., Kupfer Y., L’vov A.N. Atopic dermatitis - a neurogenic inflammatory reaction? Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2006; 4: 46-52. (in Russian)

Khagamanova I.V., Pavlova O.V. The role of stress factors in the development of chronic urticaria. Vestnik poslediplomnogo med. obrazovaniya. 2001; 2: 52-3. (in Russian)

Kemény L, von Restorff B, Michel G, Ruzicka T. Specific binding and lack of growth-promoting activity of substance P in cultured human keratinocytes. J. Invest. Dermatol. 1994; 103(4): 605-6.

Nsouli T.M., Nsouli S.M., Bellanti J.A. Neuroimmunoallergic inflamation: new patogenetic concepts and future perspectives of immediate and late allergic reaction. P.I. Ann. Allergy. 1988; 60(5): 379-89.

Lazarev A.I., Solin A.V., Lyashev Yu.D. Influence of the neuropeptide neurotensin on the development of the humoral immune response, the functional activity of macrophages and neutrophils. Kurskiy nauchno-prakticheskiy vestnik “Chelovek i ego zdorov’e”. 2005; 2: 39-43. (in Russian)

Andreeva L.A., Mezentseva M.V., Narovlyanskiy A.N., Nagaev I.Yu., Shapoval I.M., Shcherbenko V.E. et al. Prospects for the creation of new peptide drugs that have anti-infectious and immunomodulating activity. Infektsiya i immunitet. 2011; 1(2): 171-6. (in Russian)

Kuznik B.I., Tarnovskaya S.I., Lin’kova N.S., Khavinson V.Kh. Effect of dipeptide LYS-GLU and tetrapeptide ALA-GLU-ASP-GLY on the expression of the genes of pro-inflammatory, anti-inflammatory and immune cytokines. Vestnik gematologii. 2013; 9(4): 4-10. (in Russian)

Kuznik B.I., Lin’kova N.S., Tarnovskaya S.I., Dudkov A.V., Alekseev N.P. Tetrapeptide and transcription factors: the effect on the expression of immune interleukin genes. Nauchnye vedomosti. Seriya Meditsina. Farmatsiya. 2012; 22(141), vypusk 20/2: 5-10. (in Russian)

Uchakina O.N. Antiviral and immunomodulatory properties of glyiprolines. Abstract of thesis of Candidate of Biological Sciences. Moscow; 2007. (in Russian)

Torkhovskaya T.I., Belova O.V., Zimina I.V., Kryuchkova A.V., Moskvina S.N., Bystrova O.V. et al. Neuropeptides, cytokines and thymic peptides as effectors of the interaction of the thymus and neuroendocrine system. Vestnik RAMN. 2015; 70(6): 727-33. (in Russian)